Patents by Inventor Christopher Scelonge
Christopher Scelonge has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20250122513Abstract: Compositions and methods are provided for introducing transgenic target sites for Site Specific Integration (SSI) and/or polynucleotides of interest into at least one double-strand break target site of a double-strand-break inducing agent in a genomic window of a plant genome. Also provided are methods and compositions for producing a complex trait locus in a genomic window of a plant comprising at least one transgenic target site for site specific integration integrated in at least double-strand-break target site. The double-strand-break target site can be, but is not limited to, a target site for a zinc finger endonuclease, an engineered endonuclease, a meganuclease, a TALENs and/or a Cas endonuclease. The genomic window of said plant can comprise at least one genomic locus of interest such as a trait cassette, a transgene, a mutated gene, a native gene, an edited gene or a site-specific integration (SSI) target site.Type: ApplicationFiled: November 7, 2024Publication date: April 17, 2025Applicants: PIONEER HI-BRED INTERNATIONAL, INC., CORTEVA AGRISCIENCE LLCInventors: ANDREW MARK CIGAN, HUIRONG GAO, ZHAN-BIN LIU, JASDEEP MUTTI, DEAN PODLICH, CHRISTOPHER SCELONGE
-
Patent number: 12173294Abstract: Compositions and methods are provided for introducing transgenic target sites for Site Specific Integration (SSI) and/or polynucleotides of interest into at least one double-strand break target site of a double-strand-break inducing agent in a genomic window of a plant genome. Also provided are methods and compositions for producing a complex trait locus in a genomic window of a plant comprising at least one transgenic target site for site specific integration integrated in at least double-strand-break target site. The double-strand-break target site can be, but is not limited to, a target site for a zinc finger endonuclease, an engineered endonuclease, a meganuclease, a TALENs and/or a Cas endonuclease. The genomic window of said plant can comprise at least one genomic locus of interest such as a trait cassette, a transgene, a mutated gene, a native gene, an edited gene or a site-specific integration (SSI) target site.Type: GrantFiled: December 15, 2022Date of Patent: December 24, 2024Assignees: CORTEVA AGRISCIENCE LLC, PIONEER HI-BRED INTERNATIONAL, INCInventors: Andrew Mark Cigan, Huirong Gao, Zhan-Bin Liu, Jasdeep Mutti, Dean Podlich, Christopher Scelonge
-
Publication number: 20230357788Abstract: The present invention relates to plants having increased resistance or tolerance to pathogens. Such plants have reduced expression levels of CPL1 and/or ERF922. The invention further relates to methods for producing such plants, as well as methods for identifying such plants.Type: ApplicationFiled: October 16, 2020Publication date: November 9, 2023Applicant: KWS SAAT SE & Co. KGaAInventors: Daniel Fabian STIRNWEIS, Dietmar STAHL, Urs Konrad FISCHER, Christopher SCELONGE
-
Publication number: 20230212595Abstract: Compositions and methods are provided for introducing transgenic target sites for Site Specific Integration (SSI) and/or polynucleotides of interest into at least one double-strand break target site of a double-strand-break inducing agent in a genomic window of a plant genome. Also provided are methods and compositions for producing a complex trait locus in a genomic window of a plant comprising at least one transgenic target site for site specific integration integrated in at least double-strand-break target site. The double-strand-break target site can be, but is not limited to, a target site for a zinc finger endonuclease, an engineered endonuclease, a meganuclease, a TALENs and/or a Cas endonuclease. The genomic window of said plant can comprise at least one genomic locus of interest such as a trait cassette, a transgene, a mutated gene, a native gene, an edited gene or a site-specific integration (SSI) target site.Type: ApplicationFiled: December 15, 2022Publication date: July 6, 2023Applicants: E. I. DU PONT DE NEMOURS AND COMPANY, PIONEER HI-BRED INTERNATIONAL, INC.Inventors: ANDREW MARK CIGAN, HUIRONG GAO, ZHAN-BIN LIU, JASDEEP MUTTI, DEAN PODLICH, CHRISTOPHER SCELONGE
-
Patent number: 9926571Abstract: A variety of methods and compostions are provided, including methods and compositions for targeted modification of a specific target site in a cell or organism, methods for integrating polynucleotides of interest, methods to assess promoter activity, directly select transformed organisms, minimize or eliminate expression resulting from random integration into the genome of an organism, such as a plant, remove polynucleotides of interest, combine multiple transfer cassettes, invert or excize a polynucleotide, silence a gene, and identify and/or characterize transcriptional regulating regions. The methods involve the introduction of a cell proliferation factor and a double-strand break-inducing enzyme into an organism.Type: GrantFiled: March 17, 2014Date of Patent: March 27, 2018Assignee: PIONEER HI-BRED INTERNATIONAL, INC.Inventors: William Gordon-Kamm, Keith Lowe, David J Peterson, Christopher Scelonge, Grace M St Clair, Bing-Bing Wang
-
Publication number: 20140237681Abstract: A variety of methods and compostions are provided, including methods and compositions for targeted modification of a specific target site in a cell or organism, methods for integrating polynucleotides of interest, methods to assess promoter activity, directly select transformed organisms, minimize or eliminate expression resulting from random integration into the genome of an organism, such as a plant, remove polynucleotides of interest, combine multiple transfer cassettes, invert or excise a polynucleotide, silence a gene, and identify and/or characterize transcriptional regulating regions. The methods involve the introduction of a cell proliferation factor and a double-strand break-inducing enzyme into an organism.Type: ApplicationFiled: March 17, 2014Publication date: August 21, 2014Applicant: PIONEER HI BRED INTERNATIONAL INCInventors: William Gordon-Kamm, Keith Lowe, David J. Peterson, Christopher Scelonge, Grace M. St Clair, Bing-Bing Wang
-
Publication number: 20070271628Abstract: This invention relates to isolated polynucleotides encoding WUS polypeptides. The invention further provides isolated WUS polypeptides. The invention also provides methods of using the polynucleotides to modulate the level of WUS, improve transformation efficiency, to stimulate plant cell growth, including stem cells, to stimulate organogenesis, to stimulate somatic embryogenesis, to induce apomixis, and to provide a positive selection for cells comprising the polynucleotide. The invention also relates to cells, plants and seeds comprising the polynucleotides of the invention or produced by the methods of the invention.Type: ApplicationFiled: May 29, 2007Publication date: November 22, 2007Applicants: PIONEER HI-BRED INTERNATIONAL, INC., E.I. DU PONT DE NEMOURS AND COMPANYInventors: Keith Lowe, Rebecca Cahoon, Christopher Scelonge, Yumin Tao, William Gordon-Kamm, Wesley Bruce, Lisa Newman
-
Publication number: 20050144665Abstract: The present invention provides methods for identifying a genetically modified plant cell comprising a recombinase-mediated exchange between a first nucleotide sequence and a second nucleotide sequence. The present invention provides a method for obtaining a genetically modified plant cell wherein a functional recombination at both the 5? and 3? ends of the nucleotide can be identified.Type: ApplicationFiled: December 17, 2004Publication date: June 30, 2005Inventors: William Gordon-Kamm, L. Lyznik, Christopher Scelonge, Theodore Klein
-
Patent number: 6486382Abstract: A method for the production of transgenic plants is provided in which a vector carrying a gene encoding the green fluorescent protein is introduced into cells, the cells are screened for the protein and transformed cells are selected and regenerated. The cellular toxicity of the green fluorescent protein is circumvented by regulating expression of the gene encoding the protein or directing the protein to a subcellular compartment where it is not toxic to the cell. DNA constructs are provided for cell transformation in which the expression of a gene encoding the green fluorescent protein is placed under the control of an inducible promoter. In addition, DNA constructs are provided in which a nucleotide sequence encoding the green fluorescent protein is operably linked to a signal sequence which directs the expressed protein to a subcellular compartment where the protein is not toxic to the cell.Type: GrantFiled: December 20, 1999Date of Patent: November 26, 2002Assignee: Pioneer Hi-Bred International, Inc.Inventors: William Gordan-Kamm, Dorothy A. Pierce, Benjamin Bowen, Dennis Bidney, Margit Ross, Christopher Scelonge, Michael D. Miller, Gary Sandahl, Lijuan Wang